Enrollment of 108 patients completed in the registration-enabling Phase 3 CoMpass trialTopline data from the 15-month primary endpoint expected ...
Key Points Interested in Aura Biosciences, Inc.? Here are five stocks we like better. Aura Biosciences is nearing completion ...
Please provide your email address to receive an email when new articles are posted on . Belzupacap sarotalocan via suprachoroidal administration demonstrated positive interim phase 2 safety and ...
Please provide your email address to receive an email when new articles are posted on . WAILEA, Hawaii — The notion that all pigmentation in the eye is melanoma is a “rumor,” according to a speaker at ...
Aura Biosciences Inc ( (AURA)) has shared an update. On May 11, 2026, Aura Biosciences reported first-quarter 2026 results and business developments, highlighting continued progress of its global ...
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in ...
Key Points Interested in Aura Biosciences, Inc.? Here are five stocks we like better. Aura Biosciences says its lead drug bel ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aura Biosciences, a clinical-stage oncology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today ...
View Aura Biosciences Inc AURA stock quote prices, financial information, real-time forecasts, and company news from CNN.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results